Key TakeawaysGLP-1 inhibitors significantly reduce cardiovascular events and mortality, with promising results in weight reduction and heart failure symptom improvement.Clinicians should incorporate GLP-1s into practice, as they are endorsed by cardiology guidelines and show efficacy in reducing cardiovascular events.Trials like SOUL and SURPASS highlight the importance of GLP-1s in cardiology, extending their use beyond diabetes […]
